01 (Image 01)
Nifedipine Tablet, Extended Release
Product Images NDC 50090-6450
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 50090-6450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
02 (Image 02)
This is a table comparing the adverse effects of Nifedipine extended-release tablets versus the placebo in a study with 707 participants. The side effects reported included headache, fatigue, dizziness, constipation, and nausea. The percentage of participants experiencing each side effect is provided for both Nifedipine and the placebo.*
03 (Image 03)
This is a table showing the percentage of adverse effects reported by patients on Nifedipine capsules versus those on a placebo. Adverse effects reported include dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat.*
Label Image (Lbl500906450)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
